Former NCI chief and serial biotech entrepreneur raise $70 million to start companies that fail fast
Matthew Herper covers medical innovation — both its promise and its perils. Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback